|
Match
|
Document |
Document Title |
|
|
US20110182995 |
MEDICAL AND DENTAL BIOMATERIAL AND METHOD OF USE FOR THE SAME
The embodiments herein provide a dental and medical biomaterial and its use for sealing and/or filling the tooth and bone cavities. In the embodiments herein, the calcium salt, calcium oxide,... |
|
|
US20130273018 |
RECOMBINANT HUMAN CLN2 PROTEIN AND METHODS OF ITS PRODUCTION AND USE
The present invention relates to a method for treating a patient having disorder characterized by a deficient amount of functional CLN2 protein in the affected cells, which comprises administering... |
|
|
US20120014935 |
RECOMBINANT HUMAN CLN2 PROTEIN AND METHODS OF ITS PRODUCTION AND USE
The present invention relates to a method for treating a patient having disorder characterized by a deficient amount of functional CLN2 protein in the affected cells, which comprises administering... |
|
|
US20110014172 |
Recombinant Human CLN2 Protein and Methods of Its Production and Use
The present invention relates to a method for treating a patient having disorder characterized by a deficient amount of functional CLN2 protein in the affected cells, which comprises administering... |
|
|
US20140065082 |
Topical skin care formulations
A white, color-stable anti-aging emulsion formula containing CoQ10 and/or vanillin. The amount of vanillin can be adjusted to provide light or dark tanning of the skin. Lime oil and lime juice... |
|
|
US20110250153 |
OLIGOMERIC BIOSURFACTANTS IN DERMATOCOSMETIC COMPOSITIONS
Oligomeric acylated biosurfactants (“OABs”) having low critical micelle concentrations of from about 1.0 ppm to about 200 ppm, preferably less than about 50 ppm, in an aqueous solution of Minimal... |
|
|
US20150259739 |
DETERMINING AGE RANGES OF SKIN SAMPLES
The present invention provides methods for characterizing a skin sample of a subject as belonging to an age range by analyzing nucleic acid or protein molecules obtained from the subject. The... |
|
|
US20120141446 |
Oral Nutritional Supplement Delivery System
A composition for increasing the bioavailability of nutrients in humans and animals comprising an oil base emulsion into which nutrients selected from the group comprising omega fatty acids,... |
|
|
US20110318405 |
Chemical Combination and Method for Increasing Delivery of Coenzyme Q10
The present invention relates to a chemical combination and method for increasing delivery of Coenzyme Q10. The chemical combination comprises Coenzyme Q10 mixed with at least one chemical. The at... |
|
|
US20110135620 |
PRODRUG ACTIVATION IN CANCER CELLS USING MOLECULAR SWITCHES
The present invention features a novel protein engineering strategy by combining the domains of two independent proteins into a molecular switch. The invention features polypeptides comprising a... |
|
|
US20110014247 |
METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral... |
|
|
US20110142800 |
METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
This invention provides compositions comprising a protein, an absorption enhancer, a protease inhibitor, methods for treating diabetes mellitus, comprising administering same, and methods for oral... |
|
|
US20110008308 |
Composition for hair, skin, nails
A pharmaceutical composition for use in hair, skin and nail health maintenance, for combined, sequential or simultaneous administration, in any form, via any biological route. In its optimal... |
|
|
US20110086014 |
METHOD FOR ENZYMATIC CROSS-LINKING OF A PROTEIN
A method for cross-linking albumin for use as a sealant or glue for a biological system, for example to induce hemostasis and/or prevent leakage of any other fluid from a biological tube or... |
|
|
US20150098931 |
Cooperative Medication Combination Systems
This invention aims to capture and teach the high-level concept of combining doses of medications in unconventionally substandard amounts, for the treatment of medical. pathologies. By combining... |
|
|
US20150017147 |
METHODS AND PRODUCTS TO PROVIDE ORAL NUTRITIONAL CARE TO SUBJECTS WITH DEMENTIA
The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the... |
|
|
US20130216479 |
SITE-SPECIFIC CHEMICAL MODIFICATION OF PROTEINS AT THEIR N-TERMINI, ENABLING THE FORMATION OF HOMOGENEOUS ADDUCTS
Site-specific modifications of proteins at their N-termini are provided. In particular, a chemical modification of proteins at their N-termini via a transamination reaction to form homogeneous... |
|
|
US20120134976 |
ORAL FORMULATIONS FOR COUNTERACTING EFFECTS OF AGING
An oral formulation as described herein can comprise pomegranate extract, panax ginseng extract, and c. sinensis, where each is present in an amount effective to counteract and/or prevent effects... |
|
|
US20130142781 |
PEG BASED HYDROGEL FOR PERIPHERAL NERVE INJURY APPLICATIONS AND COMPOSITIONS AND METHOD OF USE OF SYNTHETIC HYDROGEL SEALANTS
Hydrogels that may be used for treating peripheral nerves and related methods are provided. Synthetic hydrogel sealants, methods of forming synthetic hydrogel sealants, and the use of synthetic... |
|
|
US20130259910 |
METHOD FOR USE OF A DOUBLE-STRUCTURED TISSUE IMPLANT FOR TREATMENT OF TISSUE DEFECTS
A method for use of a double-structured tissue implant or a secondary scaffold stand alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary... |
|
|
US20110268718 |
CACTUS FRUIT EXTRACT
A method for producing a cactus fruit extract for use in formulating a beverage which can be used in the treatment of veisalgia. |
|
|
US20130052175 |
OIL SUSPENSION-BASED MOLDED FOOD PRODUCTS
A molded food product is provided that has a high fat and protein content and a low carbohydrate content. The food product is suitable for human or animal consumption. The food product can serve... |
|
|
US20120010599 |
INORGANICALLY SURFACE-MODIFIED POLYMERS AND METHODS FOR MAKING AND USING THEM
In alternative embodiments, the invention provides articles of manufacture comprising biocompatible nanostructures comprising PolyEther EtherKetone (PEEK) surface-modified (surface-nanopatterned)... |
|
|
US20140105937 |
TOPICAL UBIQUINOL ORAL SUPPLEMENT COMPOSITIONS WITH AMORPHOUS CALCIUM PHOSPHATE
Topical, UBIQUINOL, adjunctive, supplement compositions, containing amorphous calcium phosphate fluoride (ACPF), useful in: reducing oxidative stress, relieving oral discomfort and dry mouth, and... |
|
|
US20110195058 |
CARDIOVASCULAR SUPPORT SUPPLEMENT AND COMPOSITIONS AND METHODS THEREOF
A cardiovascular support composition is provided comprising red yeast rice, Coenzyme-Q10, and phytosterols. A method for maintaining cardiovascular health is also provided comprising administering... |
|
|
US20110070218 |
METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM
A method of treating a cancer of the central nervous system in a subject in need thereof is provided. The method comprising administering to the subject a therapeutically effective amount of an... |
|
|
US20120156265 |
CONFORMABLE TISSUE REPAIR IMPLANT CAPABLE OF INJECTION DELIVERY
A conformable tissue implant is provided for use in repairing or augmenting a tissue defect or injury site. The tissue implant contains a tissue carrier matrix comprising a plurality of... |
|
|
US20150202143 |
SYSTEM, METHOD, AND KIT FOR SELECTING AND PREPARING CUSTOMIZED COSMETICS
A kit for preparing a customized cosmetic includes at least one of five cosmetic bases. Each of the five cosmetic bases correspond to at least one of a plurality of primary categories. The kit... |
|
|
US20140302014 |
METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 COMBINATION THERAPIES
Presented herein are methods for the treatment of oncological disorders by the co-administration of CoQ10 formulations and chemotherapeutic agents and/or surgery. The CoQ10 formulations may be at... |
|
|
US20130089592 |
METHOD OF PRODUCING A HYDROGEL
The invention provides a method of enzymatically modifying xylan by selectively removing glucuronic acid and/or arabinose side chains from the xylan with a-D-glucuronidase and/or... |
|
|
US20110212136 |
Nanosphere/Microsphere Delivery System for the Treatment of Spinal Cord Injury
A formulation including injectable biodegradable nanospheres and/or microspheres as a delivery system for chondroitinase ABC (cABC) or a functional derivative of cABC to treat acute and chronic... |
|
|
US20140308222 |
COMPOSITION CONTAINING EXTRACT OF VENUS FLYTRAP FOR COSMETIC TREATMENT
The present invention relates to an extract of Dionaea muscipula and a composition comprising such an extract for cosmetic treatment of the skin and skin appendages such as sebaceous glands, hair... |
|
|
US20130202541 |
COMPOSITION CONTAINING EXTRACT OF VENUS FLYTRAP FOR COSMETIC TREATMENT
The present invention relates to an extract of Dionaea muscipula and a composition comprising such an extract for cosmetic treatment of the skin and skin appendages such as sebaceous glands, hair... |
|
|
US20110104246 |
METHOD OF WOUND TREATMENT USING LIQUID GALLIUM NITRATE
A pharmaceutical composition and method for topical wound treatment by topical treatment with gallium salts, preferably gallium nitrate. In a preferred embodiment, the gallium nitrate is in an... |
|
|
US20140322237 |
NEURODEGENERATIVE DISEASES AND METHODS OF MODELING
Disclosed are embryonic stem cells and motor neurons derived from mice carrying transgenic alleles of the normal or mutant human SOD1 gene. Also disclosed are in vitro systems employing such SOD1... |
|
|
US20100316705 |
SYSTEM FOR EXSANGUINOUS METABOLIC SUPPORT OF AN ORGAN OR TISSUE
An exsanguinous metabolic support system for maintaining an organ or tissue at a near normal metabolic rate is disclosed. The system employs a warm perfusion solution capable of supporting the... |
|
|
US20110110914 |
METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
Methods and formulations for treating oncological disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described. |
|
|
US20150056176 |
ANTI-INFLAMMATORY COMPOSITION
Disclosed herein are methods of using nutritional supplements and specific combinations thereof to counteract exercise-induced inflammation in monogastric organisms. Particular embodiments focus... |
|
|
US20120107394 |
IMMUNO-COMPATIBLE HYDROGEL SYSTEM
An immuno-compatible hydrogel system is provided that is resistant to protein binding. The hydrogel system is prepared by contacting a hydrogel solution with a cross-linking agent to form a gel,... |
|
|
US20130230502 |
METHODS OF TREATING CANCER USING OPIOD RETARGETED ENDOPEPIDASES
The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions. |
|
|
US20110070211 |
Methods of Treating Cancer Using Galanin Retargeted Endopepidases
The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions. |
|
|
US20130177544 |
BIOMARKERS ASSOCIATED WITH PRE-DIABETES, DIABETES AND DIABETES RELATED CONDITIONS
Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q... |
|
|
US20130177542 |
Osteoporosis Treatment Means and Method
Supplements (non-hormonal) known to aid in bone formation and a method of spreading the supplements out throughout the day taking into consideration counteracting effects some have on others and... |
|
|
US20110274677 |
Biological Pest Control Mixture Containing D-Limonene and Nutmeg Oil
An organic pest control product comprising nutmeg oil and D-limonene is disclosed. In some embodiments the organic pest control product further comprises a miscibility enhancer to enhance the... |
|
|
US20150023941 |
Compositions Comprising Sugar-Cysteine Products
The present invention provides compositions comprising sugar, cysteine, and/or sugar-cysteine products, methods of preparing the same, and/or using the same. |
|
|
US20140348811 |
COMPOSITIONS COMPRISING SUGAR-CYSTEINE PRODUCTS
The present invention provides compositions comprising sugar, cysteine, and/or sugar-cysteine products, methods of preparing the same, and/or using the same. |
|
|
US20120058097 |
COMPOSITIONS INCLUDING A SODIUM CHANNEL BLOCKER AND A B VITAMIN MOLECULE AND METHODS OF USE THEREOF
The invention generally relates to compositions including a sodium channel blocker and a B vitamin molecule and methods of use thereof. In certain embodiments, the invention provides compositions... |
|
|
US20110123591 |
TUMORICIDAL, BACTERICIDAL, OR VIRICIDAL MACROPHAGE ACTIVATION
The activation of macrophages and methods for treating cancer, bacterial pathogens and viral pathogens are disclosed. In particular, Gc protein is converted to Gc-macrophage activating factor... |
|
|
US20110311478 |
Combinatorial Methods For Treating Cellular Proliferative Disorders And Immune Deficiencies Using Salicinium
The present invention provides novel immunotherapeutic compositions and methods useful for treating or preventing microbial infections, weakened immune systems, diseases in which cells have become... |
|
|
US20120063997 |
DELIVERY SYSTEM WITH SCAFFOLDS
An injectable, agent delivery system comprising a composition comprising: (i) an injectable scaffold material comprising discrete particles, which are capable of interacting to form a scaffold;... |